What Are Peptides? A Research-Focused Introduction to Structure, Function, and Classification

Peptides sit at an unusual crossroads in biology. They are small enough to be manufactured on a benchtop synthesizer, yet large enough to carry the kind of specific structural information that lets a molecule recognize a single receptor among thousands. That combination — chemical tractability plus biological specificity — is why peptides have become one of the fastest-growing categories in both pharmaceutical development and preclinical laboratory research [1,2].

This article is an introduction for readers encountering the term for the first time, or for those who have seen peptide names circulating without a clear sense of what unites them. It covers the chemical definition, where peptides come from, how they exert biological effects, the major functional classes studied in research settings, and the practical considerations — stability, purity, nomenclature — that determine whether peptide research is interpretable at all.

The Chemical Definition: Amino Acids and the Peptide Bond

A peptide is a short chain of amino acids joined by peptide bonds. That definition contains two components worth unpacking.

Amino acids are small organic molecules that share a common backbone: a central carbon bonded to an amino group (–NH₂), a carboxyl group (–COOH), a hydrogen atom, and a variable side chain (the "R group"). Twenty amino acids are genetically encoded in humans, and their side chains span a wide chemical range — hydrophobic, charged, polar, aromatic, sulfur-containing. This side-chain diversity is what allows short sequences to fold into distinct shapes and interact selectively with biological targets.

A peptide bond is the covalent amide linkage formed when the carboxyl group of one amino acid condenses with the amino group of the next, releasing a molecule of water. The resulting chain has directionality: an N-terminus (free amino group) at one end and a C-terminus (free carboxyl group) at the other. By convention, peptide sequences are always written N-terminus to C-terminus.

Peptides Versus Proteins

The boundary between "peptide" and "protein" is conventional rather than absolute. A common working threshold places peptides at roughly 2–50 amino acid residues, with anything longer described as a polypeptide or protein [2,3]. Some authors use a molecular weight cutoff instead, often around 5,000–10,000 daltons.

The functional distinction is arguably more meaningful than the numerical one. Proteins typically fold into stable, well-defined three-dimensional structures with hydrophobic cores and often possess catalytic or structural roles. Most peptides are too short to bury a hydrophobic core and instead exist as flexible chains in solution, adopting a defined conformation only upon binding a receptor or partner molecule. Peptides therefore tend to act as messengers rather than machines — hormones, neurotransmitters, immune modulators, and growth factors.

Naming Conventions

Peptide nomenclature can be confusing because several systems overlap. Some peptides are named by length (a dipeptide has two residues, a pentadecapeptide fifteen). Some are named for the tissue or process where they were discovered (thymosin beta-4 was isolated from thymus tissue). Others carry laboratory or development codes that were never replaced by systematic names. This is why the research literature contains a mix of descriptive names, Greek-letter designations, and alphanumeric codes for molecules that are chemically quite similar.

Where Peptides Come From

Peptides in biology arise through three broad routes.

Ribosomal synthesis and processing. Most endogenous signaling peptides begin life as larger precursor proteins encoded by genes. These pre-prohormones are cleaved by specific proteases — prohormone convertases and carboxypeptidases — into mature, biologically active fragments. Insulin, glucagon, glucagon-like peptide-1 (GLP-1), and the growth hormone–releasing hormone family all emerge this way. A single precursor can yield multiple distinct peptides depending on which enzymes are expressed in a given tissue, a mechanism called tissue-specific processing.

Non-ribosomal and degradation-derived peptides. Some peptides are assembled enzymatically without a ribosome (glutathione, a tripeptide of glutamate, cysteine, and glycine, is built by two dedicated ligases). Others are liberated when larger proteins are broken down — including bioactive fragments released during digestion of dietary protein or during extracellular matrix turnover.

Synthetic peptides. Laboratory peptides are made chemically, most commonly by solid-phase peptide synthesis (SPPS), the method introduced by Bruce Merrifield in 1963 and still the foundation of the field [4]. In SPPS, the growing chain is anchored to an insoluble resin bead while amino acids are added one at a time with protecting groups preventing unwanted side reactions. Excess reagents and byproducts are simply washed away at each step. Longer sequences are often produced recombinantly in bacterial or yeast expression systems instead.

The historical foundation for all of this was Frederick Sanger's determination of the amino acid sequence of insulin in the early 1950s — the first demonstration that a biological polypeptide has a defined, reproducible sequence rather than a random arrangement [5].

How Peptides Exert Biological Effects

The dominant mechanism is receptor binding. Most signaling peptides act on cell-surface receptors — frequently G protein–coupled receptors (GPCRs) — where binding triggers a conformational change in the receptor and initiates an intracellular cascade involving second messengers such as cyclic AMP, calcium, or phosphorylation events [3,6].

Several features follow from this mechanism:

• Specificity. Because binding depends on complementary shape and charge, peptides can be highly selective for a single receptor subtype. This underlies their generally favorable specificity profile relative to many small molecules [1,6].
• Potency at low concentrations. Receptor-mediated signaling is amplified downstream, so nanomolar or even picomolar concentrations can produce measurable cellular responses.
• Poor oral bioavailability. Peptides are substrates for the same digestive proteases that break down dietary protein, and their size and polarity limit passive membrane permeation. This is the central pharmacological challenge of the class [7].
• Short circulating half-life. Unmodified peptides are cleared rapidly by proteolysis and renal filtration, often within minutes. Much of modern peptide chemistry consists of strategies to extend this: D-amino acid substitution, N-terminal or C-terminal capping, cyclization, PEGylation, lipidation, and albumin-binding motifs [1,7].

Not every molecule discussed alongside peptides is chemically a peptide. NAD+, for instance, is a dinucleotide coenzyme, not an amino acid chain — it appears in the same research conversations because of overlapping interest in cellular energetics, but it belongs to a different chemical class. Glutathione, by contrast, genuinely is a peptide: a tripeptide, though one linked by an unusual gamma-glutamyl bond rather than a standard alpha peptide bond.

Major Classes of Peptides in Preclinical Research

Research peptides are usefully grouped by the biological system they engage.

Growth Hormone Secretagogues and GHRH Analogs

This group modulates the somatotropic axis. Growth hormone–releasing hormone (GHRH) analogs such as Sermorelin (the 1–29 fragment of native GHRH), Tesamorelin, and CJC-1295 (no DAC) act at the GHRH receptor on pituitary somatotrophs [8]. A separate mechanism operates through the ghrelin receptor (GHS-R1a): Ipamorelin was characterized as one of the first selective secretagogues of this type in pituitary models, notable in early studies for releasing growth hormone with limited effect on other pituitary hormones [9].

Metabolic and Incretin-Related Peptides

Incretins are gut-derived peptides released after nutrient intake that potentiate insulin secretion. GLP-1 biology has been mapped in extensive detail, including receptor distribution across pancreas, gut, and central nervous system [6]. Multi-receptor analogs — Tirzepatide, which engages both GIP and GLP-1 receptors, and Retatrutide, studied as a triple GIP/GLP-1/glucagon receptor agonist — represent a design strategy of combining complementary receptor pharmacology in a single molecule.

Tissue Repair and Regenerative Peptides

BPC-157 is a synthetic pentadecapeptide sequence derived from a protein found in gastric juice; it has been studied extensively in rodent injury models across gastrointestinal, tendon, and vascular tissue [10]. TB-500 corresponds to thymosin beta-4, an actin-sequestering peptide that has been described in the literature as a modulator of cell migration and wound repair processes [11]. GHK-Cu is a copper-binding tripeptide (glycyl-L-histidyl-L-lysine) first isolated from human plasma and investigated for effects on extracellular matrix gene expression in cell culture [12]. Combination preparations such as the Wolverine Blend and GLOW Blend group these compounds together for comparative laboratory work.

Mitochondrial-Derived Peptides

MOTS-c belongs to a class encoded within the mitochondrial genome rather than nuclear DNA. It was described in 2015 as a regulator of metabolic homeostasis acting in part through the folate–AICAR–AMPK pathway in mouse models [13].

Melanocortin Peptides

MT-2 is a synthetic cyclic analog of alpha-melanocyte-stimulating hormone that binds melanocortin receptors, a family involved in pigmentation, energy balance, and inflammatory signaling.

Practical Considerations in Peptide Research

Because peptides are chemically labile, experimental reliability depends heavily on handling. Most research peptides are supplied lyophilized (freeze-dried) because the solid state dramatically slows hydrolysis, oxidation, and aggregation. Sequences containing methionine or cysteine are prone to oxidation; those with asparagine or glutamine can undergo deamidation. Repeated freeze–thaw cycles of reconstituted solutions promote degradation and aggregation.

Purity and identity verification matter equally. Reversed-phase HPLC quantifies purity, while mass spectrometry confirms molecular weight and therefore sequence identity. Without both, a study cannot claim that the observed effect belongs to the intended molecule rather than to a truncated byproduct or residual synthesis reagent.

Reading the Literature Critically

Much peptide data comes from cell culture and rodent models. Translation from those systems to other species is not automatic — receptor sequences differ, metabolic clearance differs, and effective concentrations in a dish rarely correspond to achievable concentrations in a whole organism. When evaluating any peptide claim, the relevant questions are: what model system, what concentration range, what controls, and has the finding been replicated independently?

Summary

Peptides are amino acid chains short enough to synthesize chemically but long enough to encode receptor-level specificity. They function primarily as signaling molecules, they are typically fragile and short-lived, and they span a wide range of biological systems — endocrine, metabolic, regenerative, and immune. Understanding that shared chemistry is the starting point for making sense of any individual compound in the research literature.

References

1. Fosgerau K, Hoffmann T. Peptide therapeutics: current status and future directions. Drug Discovery Today. 2015;20(1):122–128.
2. Lau JL, Dunn MK. Therapeutic peptides: Historical perspectives, current development trends, and future directions. Bioorganic & Medicinal Chemistry. 2018;26(10):2700–2707.
3. Wang L, Wang N, Zhang W, et al. Therapeutic peptides: current applications and future directions. Signal Transduction and Targeted Therapy. 2022;7:48.
4. Merrifield RB. Solid Phase Peptide Synthesis. I. The Synthesis of a Tetrapeptide. Journal of the American Chemical Society. 1963;85(14):2149–2154.
5. Sanger F, Tuppy H. The amino-acid sequence in the phenylalanyl chain of insulin. Biochemical Journal. 1951;49(4):463–481.
6. Drucker DJ. Mechanisms of action and therapeutic application of glucagon-like peptide-1. Cell Metabolism. 2018;27(4):740–756.
7. Di L. Strategic approaches to optimizing peptide ADME properties. The AAPS Journal. 2015;17(1):134–143.
8. Teichman SL, Neale A, Lawrence B, et al. Prolonged stimulation of growth hormone and insulin-like growth factor I secretion by CJC-1295, a long-acting analog of GH-releasing hormone, in healthy adults. Journal of Clinical Endocrinology & Metabolism. 2006;91(3):799–805.
9. Raun K, Hansen BS, Johansen NL, et al. Ipamorelin, the first selective growth hormone secretagogue. European Journal of Endocrinology. 1998;139(5):552–561.
10. Sikiric P, Seiwerth S, Rucman R, et al. Stable gastric pentadecapeptide BPC 157: novel therapy in gastrointestinal tract. Current Pharmaceutical Design. 2011;17(16):1612–1632.
11. Goldstein AL, Hannappel E, Kleinman HK. Thymosin β4: actin-sequestering protein moonlights to repair injured tissues. Trends in Molecular Medicine. 2005;11(9):421–429.
12. Pickart L, Margolina A. Regenerative and protective actions of the GHK-Cu peptide in the light of the new gene data. International Journal of Molecular Sciences. 2018;19(7):1987.
13. Lee C, Zeng J, Drew BG, et al. The mitochondrial-derived peptide MOTS-c promotes metabolic homeostasis and reduces obesity and insulin resistance. Cell Metabolism. 2015;21(3):443–454.
14. Muttenthaler M, King GF, Adams DJ, Alewood PF. Trends in peptide drug discovery. Nature Reviews Drug Discovery. 2021;20(4):309–325.

All compounds referenced are intended strictly for laboratory research use only. They are not for human or veterinary consumption, diagnostic use, or therapeutic application.